EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review

Di Wu iD, Hongbing Zhang, Xin Li, Jinghao Liu, Minghui Liu, Hongyu Liu, Ming Dong, Jun Chen

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.14876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Di Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Sarcoma, Synovial, Lung Neoplasms, Mesothelioma, Malignant, Mesothelioma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synovial sarcoma is a highly malignant tumor that accounts for 10% of all soft tissue sarcomas. Primary pulmonary synovial sarcoma (PPSS) is extremely rare, and its prognosis is poor. A diagnosis is usually established after other primary lung malignancies or metastatic extrathoracic sarcomas have been excluded. Therefore, it is often misdiagnosed. In this study, we report the case of a 38‐year‐old woman who was misdiagnosed as having pleural mesothelioma and finally endured surgery to remove the tumor. The tumor showed SYT‐SSX fusion transcripts and was diagnosed as PPSS after combining histopathological and immunohistochemical analyses. Finally, we determined some biomarkers through whole‐exome sequencing (WES) to improve the diagnosis and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, SynovialLung NeoplasmsMesothelioma, MalignantMesotheliomaFemaleHumansAdultExome SequencingDiagnostic ErrorsOncogene Proteins, FusionBiomarkers, Tumor

Stichwörter der Autor:innen

anlotinibdiagnosis and treatmentprimary pulmonary synovial sarcomawhole-exome sequencing

Substanzen

Oncogene Proteins, FusionBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
  • Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

ORCID-Profile: Di Wu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, D., Zhang, H., Li, X., Liu, J., Liu, M., Liu, H., Dong, M., & Chen, J. (2023). Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review. Thoracic Cancer. https://doi.org/10.1111/1759-7714.14876

Vancouver

Wu D, Zhang H, Li X, Liu J, Liu M, Liu H, et al. Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review. Thoracic Cancer. 2023. doi:10.1111/1759-7714.14876

BibTeX
@article{Wu2023,
  author = {Wu, Di and Zhang, Hongbing and Li, Xin and Liu, Jinghao and Liu, Minghui and Liu, Hongyu and Dong, Ming and Chen, Jun},
  title = {Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.14876}
}
Kostenlos starten →